Home
>
National Drug Code (NDC)
>
Enalaprilat
Enalaprilat - 55154-0355-5 - (Enalaprilat)
Drug Information of Enalaprilat
| Product NDC: | 55154-0355 |
| Proprietary Name: | Enalaprilat |
| Non Proprietary Name: | Enalaprilat |
| Active Ingredient(s): | 1.25 mg/mL & nbsp; Enalaprilat |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Enalaprilat
| Product NDC: | 55154-0355 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075634 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000823 |
Package Information of Enalaprilat
| Package NDC: | 55154-0355-5 |
| Package Description: | 5 VIAL in 1 BAG (55154-0355-5) > 1 mL in 1 VIAL |
NDC Information of Enalaprilat
| NDC Code | 55154-0355-5 |
| Proprietary Name | Enalaprilat |
| Package Description | 5 VIAL in 1 BAG (55154-0355-5) > 1 mL in 1 VIAL |
| Product NDC | 55154-0355 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Enalaprilat |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20000823 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | ENALAPRILAT |
| Strength Number | 1.25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
